Duration of shedding of culturable virus in SARS-CoV-2 Omicron (BA. 1) infection
…, R Uddin, MC Choudhary, JP Flynn… - … England Journal of …, 2022 - Mass Medical Soc
Shedding of Culturable SARS-CoV-2 with Omicron Outpatients with Covid-19 were followed
serially with frequent PCR and viral-culture assessments. The SARS-CoV-2 omicron (BA. 1) …
serially with frequent PCR and viral-culture assessments. The SARS-CoV-2 omicron (BA. 1) …
Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for coronavirus disease 2019 (COVID-19)
…, R Uddin, C Marino, J Regan, JP Flynn… - Clinical Infectious …, 2023 - academic.oup.com
We enrolled 7 individuals with recurrent symptoms or antigen test conversion following
nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log 10 copies/mL) were detected …
nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log 10 copies/mL) were detected …
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
…, MF Thomas, J Regan, JP Flynn… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND SARS-CoV-2 plasma viremia has been associated with severe disease and
death in COVID-19 in small-scale cohort studies. The mechanisms behind this association …
death in COVID-19 in small-scale cohort studies. The mechanisms behind this association …
Facile synthesis of sequence‐regulated synthetic polymers using orthogonal SuFEx and CuAAC click reactions
C Yang, JP Flynn, J Niu - Angewandte Chemie International …, 2018 - Wiley Online Library
The orthogonal sulfur–fluoride exchange reaction (SuFEx) and copper(I)‐catalyzed azide–alkyne
cycloaddition (CuAAC) are employed to synthesize sequence‐regulated synthetic …
cycloaddition (CuAAC) are employed to synthesize sequence‐regulated synthetic …
SARS-CoV-2 placentitis associated with B. 1.617. 2 (Delta) variant and fetal distress or demise
LL Shook, S Brigida, J Regan, JP Flynn… - The Journal of …, 2022 - academic.oup.com
There is limited information on the specific impact of maternal infection with the SARS-CoV-2
B.1.617.2 (delta) variant on pregnancy outcomes. We present 2 cases of intrauterine fetal …
B.1.617.2 (delta) variant on pregnancy outcomes. We present 2 cases of intrauterine fetal …
[HTML][HTML] Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections
…, CM North, CA Sacks, J Regan, JP Flynn… - JCI insight, 2022 - ncbi.nlm.nih.gov
Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are
largely derived from data collected prior to the emergence of the delta variant. We followed a …
largely derived from data collected prior to the emergence of the delta variant. We followed a …
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
MC Choudhary, KW Chew, R Deo, JP Flynn… - Nature …, 2022 - nature.com
SARS-CoV-2 mutations that cause resistance to monoclonal antibody (mAb) therapy have
been reported. However, it remains unclear whether in vivo emergence of SARS-CoV-2 …
been reported. However, it remains unclear whether in vivo emergence of SARS-CoV-2 …
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
…, D Tien, S Sagar, TD Vyas, JP Flynn… - Science Translational …, 2024 - science.org
Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …
[HTML][HTML] Duration of viable virus shedding in SARS-CoV-2 omicron variant infection
…, J Regan, R Uddin, MC Choudhary, JP Flynn… - MedRXiv, 2022 - ncbi.nlm.nih.gov
Clinical features of SARS-CoV-2 Omicron variant infection, including incubation period and
transmission rates, distinguish this variant from preceding variants. However, whether the …
transmission rates, distinguish this variant from preceding variants. However, whether the …
[HTML][HTML] Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
…, J Regan, R Uddin, MC Choudhary, JP Flynn… - JCI insight, 2022 - ncbi.nlm.nih.gov
Protective immunity against SARS-CoV-2 infection after COVID-19 vaccination may differ by
variant. We enrolled vaccinated (n= 39) and unvaccinated (n= 11) individuals with acute, …
variant. We enrolled vaccinated (n= 39) and unvaccinated (n= 11) individuals with acute, …